Innovent Biologics, Inc.

OTCPK:IVBX.F 주식 보고서

시가총액: US$9.8b

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Innovent Biologics 소유권

주요 주주는 누구이며 내부자가 매수 또는 매도한 적이 있나요?

최근 내부자 거래

OTCPK:IVBX.F 회사 또는 개인의 최근 내부자 거래
날짜가치이름엔티티역할공유최대 가격
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany2,000US$5.52
11 Sep 24BuyUS$11,040JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany2,000US$5.52
11 Sep 24SellUS$223,559JP Morgan Asset ManagementCompany40,500US$5.52
11 Sep 24SellUS$85,461,245JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany15,482,177US$5.52
10 Sep 24BuyUS$57,544,602JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany10,624,087US$5.42
10 Jul 24SellUS$12,728,577Capital Research and Management CompanyCompany2,755,000US$4.62
03 May 24SellUS$4,683,731De-Chao YuIndividual906,250US$5.17
02 Feb 24BuyUS$7,773,313Capital Research and Management CompanyCompany1,869,776US$4.16
12 Jan 24BuyUS$6,636,262Capital Research and Management CompanyCompany1,292,500US$5.13
05 Jan 24SellUS$17,121,093Capital Research and Management CompanyCompany3,456,000US$4.95
25 Oct 23BuyUS$13,207,557Capital Research and Management CompanyCompany2,249,500US$5.87
17 Oct 23SellUS$2,842,373De-Chao YuIndividual502,961US$5.65
12 Oct 23SellUS$18,282,217Capital Research and Management CompanyCompany3,324,500US$5.50

내부자 거래량

내부자 구매: 내부자가 지난 3개월 동안 판매한 것보다 더 많은 주식을 구입했는지 판단하기에는 데이터가 부족합니다.

소유권 분석

IVBX.F 의 소유 구조는 어떻게 되나요?
소유자 유형공유 수소유권 비율
민간 기업10,614,5000.651%
VC/PE 기업89,475,3505.49%
개인 내부자114,734,8237.03%
일반 대중661,308,41240.5%
교육기관754,912,78446.3%

주식의 희석: 지난 해 주주들은 의미 있게 희석되지 않았습니다.

최대 주주

상위 25 주주가 회사의 49.29%를 소유하고 있습니다.
소유권이름공유현재 값변경 %포트폴리오 %
6.95%
Capital Research and Management Company
113,425,003US$680.1m-0.65%0.03%
6.76%
De-Chao Yu
110,253,778US$661.1m0.92%데이터 없음
5.49%
SDIC Innovation Investment Management Co., Ltd.
89,475,350US$536.5m0%35.66%
3.58%
The Vanguard Group, Inc.
58,440,486US$350.4m0%데이터 없음
3.39%
Eli Lilly Investment Consulting (Shanghai) Co., Ltd.
55,364,540US$332.0m0%53.37%
2.62%
BlackRock, Inc.
42,678,599US$255.9m-1.42%데이터 없음
2.23%
GF Fund Management Co., Ltd.
36,440,000US$218.5m-17.1%0.47%
1.99%
Norges Bank Investment Management
32,441,094US$194.5m116%0.01%
1.85%
Fidelity International Ltd
30,119,499US$180.6m0%0.07%
1.68%
E Fund Management Co., Ltd.
27,411,000US$164.4m0%0.22%
1.66%
Canada Pension Plan Investment Board
27,004,000US$161.9m0%0.04%
1.53%
Citigroup Inc.,Banking and Securities Investments
24,932,063US$149.5m0%0.11%
1.46%
Bosera Asset Management Co., Ltd.
23,872,000US$143.1m-0.63%0.68%
1.44%
Harvest Fund Management Co. Ltd.
23,421,288US$140.4m-9.97%0.32%
0.88%
Lav Advanced Management Company Limited
14,276,500US$85.6m0%81.73%
0.84%
FMR LLC
13,704,425US$82.2m-11.3%데이터 없음
0.77%
Temasek Holdings (Private) Limited
12,585,500US$75.5m-57.7%0.06%
0.62%
Schroder Investment Management Limited
10,080,000US$60.4m0%0.04%
0.61%
China Asset Management Co. Ltd.
9,881,751US$59.3m-0.64%0.08%
0.54%
Schroder Investment Management North America Inc.
8,744,500US$52.4m0%0.15%
0.52%
Polar Capital Holdings Plc
8,551,503US$51.3m0%0.18%
0.51%
ICBC Credit Suisse Asset Management Co., Ltd.
8,343,974US$50.0m214%0.27%
0.49%
Invesco Ltd.
8,029,000US$48.1m-1.98%0.01%
0.45%
LAV Investment Adviser Limited
7,345,000US$44.0m0%37.91%
0.43%
JPMorgan Chase & Co, Brokerage and Securities Investments
7,054,321US$42.3m94.9%0.02%